跳至主要内容
临床试验/TCTR20140418002
TCTR20140418002招募中4 期

Gabapentin as an Adjuvant Analgesic with Opioids for the Management of Metastatic Bone Pain: Randomized, Double-Blind, Placebo-Controlled Crossover Trial

The Medical Association of Thailand0 个研究点目标入组 32 人开始时间: 2014年4月18日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
32

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 70 Years(—)
性别
All

入选标准

  • 1 Age 8805 18 years
  • 2 Malignant tumors with at least one metastatic bone lesion and bone pain
  • is the major pain
  • Bone metastasis is established by radiographic confirmation CT scan MRI nuclear scan
  • 3 Numerical Rating Scale 8805 4 NRS from 0 to 10 in 24 hour period
  • preceding the screening visit
  • 4 Life expectancy 8805 30 days and Palliative Performance Scale PPS 8805 30
  • 5 Regularly scheduled and stable dose of basal opioids medication for at
  • least 24 hours
  • Stable opioid use is defined as taking a constant daily dose of MSS 8804 3 dose day as rescue medication
  • 6 No opioid related side effects 8804 Grade 2 of Cancer Therapy Evaluation
  • Program Common Terminology Criteria for Adverse Events CTCAE
  • Version 4 0

排除标准

  • 1 Hypersensitivity to gabapentin
  • 2 Unable take oral medication
  • 3 Creatinine clearance 60 mL min calculated by the Cockcroft Gault
  • 4 Current gabapentin or pregabalin use within 5 days prior to screening
  • 5 Pathologic fracture clinical or radiographic evidence of spinal
  • cord compression or cauda equina syndrome
  • 6 Chemotherapy from 2 weeks before screening throughout the study
  • 7 Radiotherapy to the pain producing lesion from 1 month before
  • screening throughout the study
  • 8 New hormone therapy or increase the dose during the study
  • 9 New bisphosphonate therapy over the course of study

研究者

发起方
The Medical Association of Thailand

相似试验